Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease ( COPD ), are the fifth-leading ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to ...

Dupilumab improved exacerbations and lung function in patients with COPD and T2 inflammation, regardless of baseline BODE index score.

Adults with COPD who used inhaled corticosteroids for more than 24 months faced higher risks for diabetes, osteoporosis, ...

In a health landscape dominated by synthetic drugs and over-the-counter inhalers, Respilean offers something radically ...

This profile has not been claimed by the company. See reviews below to learn more or submit your own review. ProAir HFA Inhalers provides respiratory relief of bronchospasm and wheezing through ...

Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended as first-line treatment unless patients have asthma/COPD overlap or frequent ...

Pulmonary embolism is a common cause of cardiovascular-associated morbidity and mortality. Although pulmonary embolism affects individuals from all demographics, the incidence of pulmonary embolism is ...

Alzheimer's disease is the most common type of dementia. While there's no cure for dementia, medications can help manage or slow down symptoms, including memory loss. Medications may also help control ...

Symptoms of pulmonary embolism (PE) and exacerbation of chronic obstructive pulmonary disease (COPD) are similar, and PE might consequently be underdiagnosed in patients with COPD. Researchers at ...

While people can develop chronic obstructive pulmonary disease (COPD) no matter where they live, the condition is more common — and has worse outcomes — in some regions of the country.